Saman Daroo 8 Knowledge-based Company

Supporter of Hemophilia Patients ، Committed to Improving and Enhancing the Quality of Life for Patients with Special Conditions

Saman Daroo 8 Company started the construction of its industrial production site in 2010 at the Khorasan Razavi Science and Technology Park in the city of Mashhad. This facility was ready for operation by the end of 2016 and is capable of producing a variety of biotechnology products.

شرکت دانش بنیان سامان داروی هشتم

Innovation and Quality Along with Success

Quality is the result of intelligent and continuous effort, not an accident!

Quality Assurance

The quality and safety of products at Saman Daroo are ensured through GMP and advanced technology.

Patient Support

Objective: Supporting patients, enhancing satisfaction and providing an exceptional treatment experience, and improving lives.

Superior Technology

Manufacturing medicines with high standards, advanced technology, and dedicated personnel.

Economic Quality

Saman Daroo, superior technology at affordable costs for patients, without compromising the quality of medications.

SaFacto AF SamanDaroo8

Safacto AF

Recombinant Human Coagulation Factor VIII - Moroctocog Alfa

Safacto AF is produced using recombinant DNA technology and functions similarly to factor VIII in the body. Injecting Safacto AF increases the plasma levels of factor VIII and can temporarily address the clotting issues in patients with hemophilia type A.